Primary Chemotherapy in Patients with Nonseminomatous Germ Cell Tumors of the Testis and Biological Disease Only After Orchiectomy
- 1 April 1996
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 155 (4) , 1296-1298
- https://doi.org/10.1016/s0022-5347(01)66248-7
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: an Eastern Cooperative Oncology Group trial.Journal of Clinical Oncology, 1995
- The Management of Patients with Nonseminomatous Germ Cell Tumors of the Testis with Serologic Disease Only After OrchiectomyJournal of Urology, 1994
- High-dose chemotherapy with etoposide, cyclophosphamide and escalating dose of carboplatin followed by autologous bone marrow transplantation in cancer patients. A pilot studyEuropean Journal Of Cancer, 1993
- Treatment of good-risk disseminated non-seminomatous germ cell tumours: the less bleomycin, the more cisplatin?European Journal of Cancer and Clinical Oncology, 1991
- Long-term survivors after salvage high dose chemotherapy with bone marrow rescue in refractory germ cell cancerEuropean Journal of Cancer and Clinical Oncology, 1991
- Serum tumor markers and patient allocation to good-risk and poor-risk clinical trials in patients with germ cell tumorsCancer, 1991
- Treatment of testicular cancer: a new and improved model.Journal of Clinical Oncology, 1990
- Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol.Journal of Clinical Oncology, 1989
- Stage II Nonseminomatous Germ Cell Tumors of the Testis: An Analysis of Treatment Options in Patients with Low Volume Retroperitoneal DiseaseJournal of Urology, 1988
- A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors.Journal of Clinical Oncology, 1988